Loading clinical trials...
Loading clinical trials...
Preclinical ex Vivo Patient-derived 3D Cultures for the Prediction of Prostate Cancer Treatment Response
Conditions
Interventions
HDR brachytherapy
Diagnostic biopsy
Locations
3
Netherlands
Zuyderland Medisch Centrum
Heerlen, Limburg, Netherlands
Academisch Ziekenhuis Maastricht
Maastricht, Limburg, Netherlands
Maastricht Radiation Oncology
Maastricht, Limburg, Netherlands
Start Date
March 15, 2026
Primary Completion Date
September 30, 2031
Completion Date
December 30, 2031
Last Updated
April 23, 2026
NCT06594926
NCT07177937
NCT06844383
NCT05919264
NCT06487507
NCT06257264
Lead Sponsor
Maastricht Radiation Oncology
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions